K Yamaoka Selected Research

K Yamaoka Research Topics

Disease

2	Fibrosis (Cirrhosis) 01/2022 - 01/2020
2	Contracture 01/2022 - 01/2020
2	Inflammation (Inflammations) 01/2022 - 04/2012
2	Breast Neoplasms (Breast Cancer) 11/2020 - 11/2017
2	Pain (Aches) 04/2013 - 02/2010
2	Neoplasms (Cancer) 12/2000 - 03/2000
2	Infections 08/2000 - 01/2000
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 06/2015
1	Necrosis 04/2013
1	Hyperalgesia 04/2013
1	Neuralgia (Stump Neuralgia) 04/2013
1	Hyperglycemia 01/2013
1	Rheumatoid Arthritis 04/2012
1	Adenocarcinoma 07/2005
1	Carcinoma (Carcinomatosis) 07/2005
1	Hemorrhage 02/2002
1	Osteopetrosis 02/2002
1	Fatty Liver 09/2001
1	Pneumoconiosis 06/2001
1	Arteriosclerosis 01/2001
1	Postmenopausal Osteoporosis 01/2001
1	Spinal Fractures 01/2001
1	Hemolytic-Uremic Syndrome 07/2000
1	Hepatitis 04/2000
1	Liver Cirrhosis (Hepatic Cirrhosis) 04/2000
1	Liver Diseases (Liver Disease) 04/2000
1	Glioblastoma (Glioblastoma Multiforme) 03/2000
1	Glioma (Gliomas) 03/2000
1	Astrocytoma (Pilocytic Astrocytoma) 03/2000
1	Essential Hypertension 01/2000
1	Autoimmune Hemolytic Anemia (Cold Agglutinin Disease) 01/2000
1	Cartilage-hair hypoplasia 01/2000

Drug/Important Bio-Agent (IBA)

3	RadonIBA 04/2013 - 01/2001
2	CalciumIBA 01/2001 - 01/2000
1	Mitomycin (Mitomycin-C)FDA LinkGeneric 01/2020
1	CollagenIBA 01/2020
1	TNF Receptor-Associated Factor 6 (TRAF6)IBA 06/2015
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 04/2013
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 04/2013
1	Blood Glucose (Blood Sugar)IBA 01/2013
1	tofacitinibIBA 04/2012
1	Interleukin-6 (Interleukin 6)IBA 04/2012
1	CytokinesIBA 04/2012
1	Interleukin-8 (Interleukin 8)IBA 04/2012
1	Janus Kinase InhibitorsIBA 04/2012
1	Freund's AdjuvantIBA 02/2010
1	Thyroid Nuclear Factor 1IBA 07/2005
1	Uroplakin IIIIBA 07/2005
1	monoclonal antibody D2-40IBA 07/2005
1	Keratins (Keratin)IBA 07/2005
1	Estrogen ReceptorsIBA 07/2005
1	Progesterone Receptors (Progesterone Receptor)IBA 07/2005
1	Carcinoembryonic AntigenIBA 07/2005
1	Apoprotein(a) (Apolipoprotein (a))IBA 07/2005
1	Surface-Active Agents (Surfactants)IBA 07/2005
1	Adenosine Triphosphatases (ATPase)IBA 02/2002
1	Interferon-gamma (Interferon, gamma)IBA 02/2002
1	Vitamin D FDA LinkGeneric 02/2002
1	Alanine Transaminase (SGPT)IBA 09/2001
1	Adenosine Triphosphate (ATP)IBA 06/2001
1	LDL CholesterolIBA 01/2001
1	Lipid PeroxidesIBA 01/2001
1	Oxygen (Dioxygen)IBA 01/2001
1	Etidronic Acid (HEDP)FDA LinkGeneric 01/2001
1	Superoxide DismutaseIBA 01/2001
1	alfacalcidolIBA 01/2001
1	LDL Lipoproteins (beta Lipoproteins)IBA 01/2001
1	Cytostatic AgentsIBA 12/2000
1	Antineoplastic Agents (Antineoplastics)IBA 12/2000
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 08/2000
1	Platelet Activating FactorIBA 07/2000
1	ConnexinsIBA 04/2000
1	Gap Junction beta-1 ProteinIBA 04/2000
1	Proteins (Proteins, Gene)FDA Link 03/2000
1	Peptides (Polypeptides)IBA 03/2000
1	Messenger RNA (mRNA)IBA 03/2000
1	Galectin 1 (LGALS1)IBA 03/2000
1	Cholecalciferol (Vitamin D3)FDA Link 01/2000
1	hydroxide ionIBA 01/2000
1	Hormones (Hormone)IBA 01/2000
1	Interleukin-2 (IL2)IBA 01/2000
1	Calcitriol Receptors (Calcitriol Receptor)IBA 01/2000
1	Parathyroid Hormone (Parathormone)IBA 01/2000

Therapy/Procedure

2	Myotomy 01/2022 - 01/2020
2	Drug Therapy (Chemotherapy) 11/2020 - 11/2017
2	Therapeutics 04/2013 - 01/2001
1	Low-Level Light Therapy (LLLT) 01/2022
1	Anterior Cruciate Ligament Reconstruction 01/2022
1	Injections 01/2020
1	Intra-Articular Injections 01/2020